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ABSTRACT 
Aberrant neuronal connectivity in utero may underlie the association between fetal 
growth restriction (FGR) and increased risk for later cognitive disorders and encephalopathy. 
This study examines changes in synaptic development and myelination focussing on the 
hippocampus using a guinea pig model of placental insufficiency. Placental insufficiency was 
induced at mid-gestation by uterine artery ligation or cauterization which produced fetuses with a 
range of body weight and proportion at term. Synaptic markers, synaptophysin and 
synaptopodin, were decreased in FGR animals suggesting fewer synapses were formed and 
furthermore that fewer synapses matured with symmetrical growth restriction when compared to 
appropriate for gestational age guinea pigs. Myelination, measured using myelin basic protein 
and luxol fast blue, was also reduced in FGR animals and increased in large animals compared to 
appropriate size for gestational age guinea pigs. Therefore, neuronal connections altered with 
FGR and may spur difficulties in early childhood neurodevelopment and various neurological 
sequellae.  
KEYWORDS 
Fetal growth restriction, brain development, guinea pig, synaptogenesis, myelination, 
synaptophysin, synaptopodin, myelin basic protein, luxol fast blue, hippocampus 
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1.1 CLINICAL RELEVANCE 
1.1.1 Incidence and classification of FGR 
Pathological restriction of growth in utero is an expanding area of research aimed at 
understanding both the etiology of growth restriction and its continued impact on health. The 
Canadian Perinatal Health Report of 2004 stated that the nation-wide occurrence of low weight 
at birth (below 2500 g) has been steady for fifteen years with a rate of 5.9%. The reason for this 
statistic is multi-faceted, encompassing the decreasing rate of small-for-gestational age term 
births (those falling in the smallest 10th percentile based on birth weight) and an increasing rate 
of preterm birth prior to 37 weeks gestation (Public 2008). Growth restriction is defined 
clinically and in the research setting as below the 10th, 5th, or 3rd percentile for a given gestational 
age or below one or two standard deviations from a control group. In Canada, following the 
World Health Organization standards, fetal growth restriction (FGR) is below the tenth 
percentile for gestational age and less than 2500 g at term. (Ghidini 1996; Kramer 2003; 
Lackman 2001; Pollack 1992; Salafia 2006). These definitions are not always able to identify 
genuine FGR which is a failure to attain genetic growth potential during fetal life. Specificity of 
terminology across clinicians, researchers, and the public would improve information exchange.  
Early discrimination identifying pathological FGR from inherently small fetuses in utero 
is important, as misdiagnosed small and healthy fetuses as FGR dissipates resources. Applying 
ethnicity-specific growth curves is important in correctly characterizing FGR (Gardosi 2009, 
George 2009; Kierans 2008). A Canadian standard growth curve applied to a Kaniyambadi 
population identified a greater number of FGR babies than a standard South Asian growth curve 
or a decade old Indian growth curve (George 2009). Customized growth curves accounting for 
maternal, environmental and socioeconomic factors strongly correlated with FGR may be 
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beneficial for identifying pathological FGR (Arbuckle 1993; Figueras 2007; Gardosi 2009; 
Hutcheon 2010; Kierans 2008; Kramer 2001). A child of a mother 10 cm taller and 10 kg heavier 
than an average sized mother would have an expected mean body weight at term 140 g heavier 
than a child born to an averaged sized mother (Gardosi 2009). Thus, identification of FGR would 
require a higher threshold based on this maternal size to avoid misdiagnosis of FGR. Customised 
growth curves result in a reclassification of 2.7-4.3% of babies (Figueras 2007). Early and 
correct classification of FGR through serial ultrasounds would allow for proper intervention and 
treatment through gestation. 
There are other prognosticators of fetal growth used as adjuncts to fetal growth curves. 
Ponderal index is the ratio of weight-to-height3 and is positively correlated with fetal weight and 
nutritional status at term (Brandi 2003). Also, amniotic fluid total protein concentration is 
negatively correlated with fetal weight (Tisi 2004). A study from London, Ontario at St Joseph’s 
Health Centre found placental weight to have a positive relationship with birth weight, but other 
studies find this relationship variable unless examining large fetuses (Lackman 2001; Pollack 
1992). It is a functional reduction in the placenta rather than a decrease in placental size that is an 
important indicator of fetal growth. Markers for fetal size and shape at a particular gestational 
age are useful as they can predict the health of a fetus and postnatal outcome. 
FGR phenotypically presents as symmetrical (sFGR) or asymmetrical (aFGR) growth 
restriction, based on body proportion. The sFGR fetus has reduced growth measurements earlier 
in pregnancy, wherein brain growth inhibition remains proportional to reductions in weight, 
length and head circumference with a normal ponderal index at birth (al Riyami 2011; Halliday 
2009; Kramer 1990; Pallotto 2006; Pollack 1992). The aFGR fetus has late-onsetting growth 
restriction in the latter half of gestation (al Riyami 2011; Halliday 2009), accompanied by ‘brain 
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sparing’ where brain size and head circumference is relatively maintained through to term in 
order to maximize fetal survival (al Riyami 2011; Campbell 1977; Jones 1983; Halliday 2009; 
Laferber 1984; and Pallotto 2006), whereas skeletal muscle is wasted and there is a reduction in 
soft tissue mass (Pollack 1992, Villar 1990). aFGR phenotypically presents at term as a low 
ponderal index reflective of disproportionate body dimensions. Additional indices in utero are 
used to infer proportionality. Head-to-abdomen circumference ratio, as measured by ultrasound, 
reflects brain sparing, skeletal wasting and reduction in soft tissue mass (al Riyami 2011). 
Campbell et al. differentiated between aFGR and sFGR with echograms of head and abdomen 
circumference showing aFGR fetuses have ratios above the 95th percentile, while sFGR fetuses 
are within the normal distribution (Campbell 1977). Unlike aFGR, sFGR can be difficult to 
distinguish from constitutively small fetuses because they are proportionally similar, but extreme 
early disparity from a growth curve or evidence of a severe antenatal condition infers 
pathological sFGR.   
The most reliable method for distinguishing aFGR and sFGR is the brain-to-liver weight 
ratio; with aFGR disproportional with a decrease in liver weight, but a relatively normal head 
circumference and brain size, while sFGR have small livers and brains but proportionally similar 
to appropriate for gestational age (AGA) fetuses (Cox 2009). Accordingly, brain-to-liver weight 
ratio is often used in animal studies to accurately identify aFGR at necropsy, whereas the head 
circumference-to-abdominal circumference ratio measurements serves as a proxy for the brain 
sparing process and disproportional phenotype in human fetuses and newborns. A low brain-to-
liver weight ratio occurs in large for gestation (LGA) newborns who often are born from mothers 
with gestational diabetes (Cox 2009). The higher the brain-to-liver weight ratio the more 
sensitive it is for detecting aFGR; a ratio of 4 or more has a sensitivity of 85%, a ratio of 5 or 
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more has a sensitivity of 93%, and a ratio of 6 or more has a sensitivity of 97% (Cox 2009). 
More accurate identification of growth restriction and symmetry of growth could be obtained 
with serial in utero measurements of body, brain and liver size throughout gestation using 
ultrasound or more elegant imaging means.  
  aFGR is reported to occur in 70% of growth restricted fetuses (Campbell 1977). 
Interestingly, Villar et al. examined the proportion of aFGR and sFGR (defined by low and 
appropriate ponderal index, respectively) across the world and found that asymmetrical growth 
restriction occurs in 60-80% of growth restricted babies in developed countries whereas 
symmetrical growth restriction occurs more frequently in developing countries constituting 69-
79% of growth restricted babies (Villar 1986). There is an abundance of literature regarding 
aFGR as a pathological condition; however sFGR is less studied because of the difficulties in 
early and accurate diagnosis. A sub-analysis comparing sFGR and aFGR to AGA fetuses at the 
same gestational age is rarely reported and difficulties in such an analysis arise because of the 
overlap of etiology. 
 
1.1.2 Etiology of FGR  
The greatest percent increase in body weight occurs early in pregnancy during 
embryogenesis due to the rapid replication of cells, organogenesis and cellular hyperplasia. In 
the third trimester, the highest absolute weight gain coincides with cellular hypertrophy and 
differentiation while tissues mature (Cox 2009; Pollack 1992). Normal fetal growth depends on 
the genetic growth potential of the fetus, the efficiency of the placenta in transporting nutrients 
and oxygen and the state of the maternal environment. FGR is induced when these essential 
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factors create a sub-optimal intrauterine environment that is incapable of sustaining normal 
growth and development. Fetal causes of FGR include abnormal karyotype, infections, errors of 
metabolism, multiple fetuses, or malformations (Cetin 2004; Han 1993; Pollock 1992). In cases 
of abnormal cord insertion, multiple placental infarcts, placenta previa, abrupto placenta, or 
multiple gestations, the placenta is the primary cause of FGR (Pollack 1992). Maternal causes 
include malnutrition, hypertension, hypoxic conditions, vascular disease or environmental 
choices such as substance abuse (Feng 2005; Pollock 1992). Additionally, epidemiological 
studies show FGR to be associated with lower socio-economic status, parental education, 
maternal age, maternal height and previous delivery history (Gardosi 2009; Pallotto 2006). 
However, sixty percent of FGR is idiopathic deriving from a combination of factors, the majority 
of which are related to some form of abnormal placental development deemed placental 
insufficiency (Ghidini 1996; Pallotto 2006; Pollack 1992). 
1.1.2.1 Placental insufficiency 
The human placenta is hemochorial wherein maternal blood is in direct contact with fetal 
tissue. It has a complex branching system of fetal villi that constitute the main area of fetal-
maternal exchange. At 21 days post-conception, the secondary villi undergo vasculogenesis, 
forming the fetoplacental blood vessels (Kingdom 2000). Thereafter, placental nutrient transfer 
increases throughout gestation transforming the initially hypoxic in utero environment to one 
that is able to sustain a surge in fetal weight gain in the latter half of gestation. This is achieved 
by a 10-fold increase in volume of the vasculature within the villi, an increase in the surface area 
of the villi and a decrease in trophoblast thickness thereby reducing the materno-fetal diffusion 
distance from 55.9 µm to 4.8 µm (Myatt 2006). The basic function of the placenta is to transfer 
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blood and within it, the essential substrates, nutrients and oxygen required to support fetal 
development.  
Placental insufficiency is a general term used to describe any complication in placental 
function that results in an inefficiency in the transfer of sufficient oxygen and nutrients for fetal 
growth. This inefficiency or dysfunction can arise from poor extravillous cytotrophoblast 
invasion, increased umbilical cord length, reduced density of stem arteries, tertiary villi 
maldevelopment, thrombosis, or abnormal patterning of the chorionic plate (Chaddha 2004; 
Kingdom 2000).  These alterations may result in FGR due to inefficient blood flow and thereby 
inadequate oxygen, glucose and essential amino acid transfer to the fetus (Jansson 1990; 
Mehendran 1993; Jones 1983; Sparks 1985; Myatt 2006). Under such conditions, the fetus 
adapts its metabolic and developmental processes in order to ensure survival at the expense of 
appropriate growth. Ultrasound, Doppler measurements and MRI can be used in an attempt to 
identify uteroplacental blood flow changes and fetal vascular redistribution that are associated 
with early or late-onset FGR. 
Ninety percent of early-onset FGR is associated with abnormal umbilical Doppler 
ultrasound. The blood flow abnormality that typically presents in sFGR is a reduced, absent or 
reversed end-diastolic flow velocity in the umbilical artery as measured by Doppler ultrasound 
(Kingdom 2000; Krebs 1996). Using electron microscopy, Krebs et al. discovered fewer terminal 
villi in placenta of second trimester sFGR fetuses compared to age matched controls (Krebs 
1996). It was also found that capillary looping which functions to increase fetoplacental surface 
area was diminished in number and volume in sFGR placenta consequently impairing oxygen 
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extraction (Jackson 1994; Krebs 1996). Under-endowment in gas-exchanging villi and related 
placental insufficiency seem to be a common underlying pathology in sFGR fetuses.   
aFGR presents with normal Doppler waveforms in the umbilical artery in the majority of 
cases or else abnormal Doppler waveforms occur later during gestation but usually are not severe 
or associated with absent or reversed end-diastolic flow. Hershkovitz et al. used Doppler 
ultrasound and found abnormal middle cerebral artery waveforms but normal umbilical 
waveforms to be present in a FGR fetus with head circumference-to-abdominal circumference in 
the 95th percentile (Hershkovitz 2000). Also, frequently encountered in aFGR is a mature 
placenta at term, placental thrombosis, avascular villi, infarcts, terminal villi hypoplasia and a 
thin umbilical cord (Cox 2009; Feng 2005). The normal response of the placenta in a hypoxic or 
mal-nourished environment is to increase villous branching and capillary growth in order to 
increase surface area for gas exchange (Kingdom 2000). This response leads to accelerated 
placental maturation and a normal to large placental weight in relation to fetal weight which 
becomes superfluous when uptake efficiency of the placenta if reduced. Placental transport is 
impaired in aFGR because amino acid transporters have a reduced rate of activity on both the 
maternal and fetal membranes (Mehendran 1993).  This placental dysfunction is particularly 
detrimental in late gestation during the surge in fetal growth that occurs prior to term, thereby 
leading to the brain sparing response and morphologic phenotype of aFGR.  
1.1.2.2 Developmental origin of symmetrical FGR 
In an American population, 8.6% of all live births fall two standard deviations below 
normal birth weight, usually coinciding with the 3rd percentile of body weight, and 30% of those 
are sFGR, with normal ponderal index or body proportions (Feng 2005). sFGR onsets earlier in 
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pregnancy resulting from an interruption in cell proliferation that affects all organs equally and 
often can be diagnosed when the size of the organ does not reflect its maturity (Cox 2009). 
Impairments in cellular hyperplasia cause a proportional decrease in size of all the fetal organs 
(Pollack 1992). Skin fold thickness measurements in sFGR neonates indicate reduced fat 
deposition compared to normally grown neonates but more than aFGR neonates (Rodriguez 
2011). As such, the sFGR fetus develops in parallel with growth curves, following the shape of 
normal growth patterns but delayed and below the 5th percentile (Cox 2009). sFGR is more often 
due to a fetal cause, with either congenital abnormalities including trisomies 13,18, and 21 or 
infections (Feng 2005; Cox 2009). Often genetic disorders coincide with other phenotypic 
maladies such as dismorphic facial appearance or skeletal abnormalities. Earlier-onsetting sFGR 
is more difficult to diagnose with increased risk for fetal/neonatal mortality or preterm birth.  
1.1.2.3 Developmental origin of asymmetrical FGR 
aFGR onsets later in pregnancy, when growth is dependent on adequate placental blood 
flow, fat deposition, and nutrition. During this time, growth is less dependent on cell division and 
more on cellular hypertrophy and therefore this suboptimal environment leading to growth 
restriction will affect organ maturity, depending on its timing, and may lead to relatively atrophic 
organs (Cox 2009; Feng 2005). Examination of skin fold thickness in Caucasian newborns with 
aFGR, demonstrated reduced subcutaneous and central fat deposition relative to normally grown 
and sFGR babies (Rodriguez 2011).  As well, aFGR is associated with reduced amniotic fluid 
volume and essential amino acids near term thus indicating reduced oxygenation and substrate 
availability (Hershkovitz 2000; Jansson 1990). aFGR development follows normal fetal growth 
curves until crossing the curve with diminishing estimated weight in the last half of gestation; 
timing that coincides with fat deposition and an increased requirement for amino acids during the 
10 
 
exponential growth spurt in the third trimester of pregnancy (Cox 2009).  Under these conditions, 
the aFGR fetus adapts by means of redistributing cardiac output in order to protect essential 
organs.  
‘Brain sparing’ is the maintenance of brain growth and other vital organs such as the 
adrenals and heart by redistributing cardiac output both centrally and peripherally at the expense 
of other organs (Barker 1998). Late gestation fetuses have mature mechanisms of cardiovascular 
regulation which redirect circulating oxygen and nutrients in favour of the brain at the expense of 
the viscera, in order to maximize fetal survival (al Riyami 2011; Cox 2009; Laferber 1984). This 
redistribution of blood flow is apparent in Doppler assessment of the middle cerebral artery 
showing an increase in blood flow associated with aFGR (Hershkovitz 2000). Changes in brain 
growth with aFGR that might be occurring would not necessarily be reflected by head 
circumference, which is often a measure used to identify aFGR, as cranial growth is subsequent 
to altered brain growth (Duncan 2005). Therein, brain and head size may be reasonably well 
maintained relative to body size in aFGR, but there could still be subtle alterations in brain 
development affecting neurological health.    
 
1.1.3 FGR and life-long health 
FGR is the second most common complication in newborns behind preterm birth. Al 
Riyami et al. examined human early-onset sFGR in pregnant humans and found that only 50% of 
these fetuses survived to term (al Riyami 2011). A group in British Colombia reported a gender 
effect where females have a better chance of surviving FGR compared to males (Synnes 2010). 
